RVVTF·761516103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic
CS
RVVTF (Revive Therapeutics Ltd) is held by 0 institutional investors as of Q4 2024.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer